Validation of Portable Monitoring Device for Diagnosing Sleep Apnea

portable monitoring device could diagnose sleep apnea in high risk patients.

Completed

Looking for future studies?

Key information

Conditions

Sleep Apnea Apnea Dyssomnias Nervous System Diseases Respiration Disorders Respiratory Tract Diseases Sleep Apnea Syndromes Sleep Disorders, Intrinsic Sleep Wake Disorders

Sex eligibility

All sexes

Study type

Observational

Primary location

The Chinese Univerisity of Hong Kong

Hong Kong, China

About this study

This is a pilot study of another larger cohort investigating different algorithms in managing patients suspected of sleep apnea using portable monitoring device.

Portable monitoring device is applied simultaneously with PSG to compare it's accuracy and validity.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients suspected of sleep apnea

Exclusion criteria

patient refuse to participate

Treatment and study plan

ARES (Apnea Risk Evaluation System)

Device

application of portable monitoring device with PSG

Primary outcomes

validity of portable monitoring device

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Chinese University of Hong Kong

Other

Registry information

Official study title

A Validation Study of A New Diagnostic Device for Screening of Obstructive Sleep Apnea in High Risk Patient Population

Important dates

Study start: 2007
Primary completion: 2007
Study completion: 2008
First posted: Mar 5, 2008
Registry last updated: Feb 9, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed